Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lot of trials with Keytryda, al lot if news today see AIM and AEMD
If so then a PR before opening marker
We will see
They keep presenting, must be good reasons why
Sept 26 (Reuters) - Nel ASA NEL.OL : * PRESS RELEASE: AWARDED GRANT FOR DEVELOPMENT OF AN ADVANCED PILOT PRODUCTION LINE FOR ELECTROLYSERS * GRANT OF NOK 9.25 MILLION FROM NORWEGIAN PUBLIC ENTERPRISE ENOVA SF * NEL HYDROGEN ELECTROLYSER AWARDED A GRANT OF NOK 9.25 MILLION FROM NORWEGIAN PUBLIC ENTERPRISE ENOVA SF * ENGINEERING PHASE FOR ADVANCED PILOT PRODUCTION LINE WILL LAST UNTIL END OF 2019, AND IF SUCCESSFUL WILL CONTINUE INTO AN EXECUTION PHASE, INVOLVING CONSTRUCTION AND OPERATION OF PRODUCTION LINE FROM 2020 ONWARDS Source text for Eikon: ID:nWkr2Qg7Bm Further company coverage: NEL.OL (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Indeed not normal
Premarket 3,28
If do there is no need coming here anymore
so byby
No volume ? Nobody wants to sell shares that’s why just some game playing like you do all the time
When PPS Goes up Sand keep speechless
There will be another rett syndrome trial for less than 18 years old persons
That’s what Missling said in an answer to the the last question
New Corporate presentation today
https://www.advaxis.com/wp-content/uploads/2019/07/ADXS-Corporate-Presentation-July-2019-v.3.pdf
Will there be a read-out of the Phase 3 AIM2CERV Study ?
In an earlier Corporate presentation it was mentionned there will be partners in the first half 2019
You’ve seen anything ? It’s not there anymore, what to believe for the future ?
Where us the shareholders value as lang times predicted ?
Sent IR A few mails last days asking what they are doing and give shareholders fair explanation but no answer at all / seen premarket already ?
Didn.t they always said they have the needed funds so no dilution
Indeed and with partners from all continents
This is from november 2018; I would like to see the results now
Based on discussions over the past several months with a number of experts in the field regarding our AIM2CERV trial, we have become increasingly optimistic about the prospects of this study. We believe that continuing to invest in this study, along with certain other product candidates, provides us with a diversified portfolio across drug constructs, cancer types and stages of development,” said Kenneth A. Berlin, President and Chief Executive Officer of Advaxis. “We believe this approach affords the best opportunity to demonstrate the therapeutic potential of drug candidates generated from our unique and proprietary Lm platform.” He concluded, “The redesign of AIM2CERV with an earlier interim analysis would allow us to alter course or, if necessary, stop the study, depending on the results. If the FDA accepts our proposed revisions, we anticipate having a recommendation based on the interim analysis from the data monitoring committee as early as the fourth quarter of 2020.”
And I would know who those experts are.
Maybe this is the reason why Petit left as active member.
Otherwise they can now publish some results and maybe there will be some interest by others to end the trial and buy this out ?
Down with less volume
tomorrow friday
Beyond Seizures: Clinical Study Program ANAVAX2-73 in Neurodevelopmental Diseases
Christopher Missling, PhD, Anavex Life Sciences Corp
Where did I say that ?
Just sharing info
Very strange Indeed and now hold lifted ?
Why leaving and staying as a member at Scientific Advisory Board, ?